Surgical service spectrum:

Diagnosis, consultation, surgical treatment and follow-up of patients of all ages with:

  • Bone and soft tissue sarcomas
  • Benign bone tumors and tumor-simulating lesions
  • Benign soft tissue tumors


  • Full spectrum of tumor endoprosthetics, including growth endoprosthetics.
  • Use of patient-specific resection templates and implants (see also HSM)
  • Biological reconstructions after resection of bone tumors (sarcomas), e.g.
    • Fibula repositioning with vascular connection if necessary,
    • Replantation of the patient’s own bone after extracorporeal irradiation,
    • Rotationplasty ,
    • Biological pelvic reconstruction, etc.
  • Resection of soft tissue sarcomas with plastic reconstruction under functional and cosmetic aspects
  • Isolated hyperthermic extremity perfusion in patients with locally advanced soft tissue sarcomas


Radio-oncology service spectrum:

Consultation, full spectrum of external and internal radiation treatment, and follow-up of patients of all ages with:

  • Malignant tumors of the bone and soft tissues (sarcomas).
  • Benign bone tumors and tumor-simulating lesions
  • Benign soft tissue tumors


  • Extracorporeal bone irradiation
  • Intensity Modulated Radiation Therapy (IMRT)
  • Image guided radiation therapy (IGRT)
  • Stereotactic radiotherapy and radiosurgery in the skull and trunk for sarcomas and metastases
  • Radiation therapy for superficial tumor diseases as well as benign diseases of the joints or structures near the joints
  • Whole-body and whole-skin irradiation


Oncological service spectrum:

Diagnosis, consultation, preoperative and postoperative treatment and follow-up of patients of all ages with:

  • Malignant bone tumors (bone sarcomas)
  • Malignant soft tissue tumors (soft tissue sarcomas)

The treatment of sarcoma patients is very complex and is always carried out on an interdisciplinary basis in cooperation with surgeons, radiation therapists and oncologists. In the interdisciplinary tumor board, the individually optimal multimodal therapy is jointly determined for each patient. The Oncology Department offers the entire treatment spectrum of system therapy, so neoadjuvant, adjuvant and palliative therapy concepts are applied clinically. In metastatic situations, the focus is on systemic therapy. In addition to established standard therapies, innovative therapeutic approaches are also used within the framework of or in accordance with national and international clinical studies, which are organized via the study center of our Oncology Department. Through our integration in various national and international working groups (e.g. COSS, ISG, SSG), we have the opportunity to offer our patients with this rare disease optimal care. Due to our center function, we also have easier access to innovative drugs, so that we can provide our patients with the best possible treatment according to the current state of knowledge. In addition to system therapy, the therapeutic spectrum also includes supportive therapy including palliative medicine, pain therapy, among others also ensured by our Pain Service and psycho-oncological care by the Psychosomatic Department in our hospital.

Link studies:

EURAMOS 1: A randomized trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy.

EURO-B.O.S.S: European Bone Over 40 Sarcoma Study (A European treatment protocol for bone-sarcoma in patients older than 40 years) – open study –

CWS Registry SoTiSaR: A Registry for soft tissue sarcoma and other soft tissue tumours in children, adolescents, and young adults (treatment following study).

EWING2008: A phase 3, open label, multi- centre randomised trial of international study groups with the intention of optimising treatment results in patients with localised and advanced Ewing sarcomas (treatment according to study).